Advisory Services Network’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8
| Closed | -$1.06K | – | 2846 |
|
|
2023
Q4 | $1.06K | Buy |
+8
| New | +$1.06K | ﹤0.01% | 3523 |
|
|
2023
Q2 | – | Sell |
-78
| Closed | -$7.9K | – | 2823 |
|
|
2023
Q1 | $7.9K | Sell |
78
-2
| -3% | -$202 | ﹤0.01% | 2971 |
|
|
2022
Q4 | $9.56K | Buy |
+80
| New | +$9.56K | ﹤0.01% | 2882 |
|
|
2021
Q3 | – | Sell |
-248
| Closed | -$24K | – | 2564 |
|
|
2021
Q2 | $24K | Buy |
+248
| New | +$24K | ﹤0.01% | 2423 |
|
|
2021
Q1 | – | Sell |
-306
| Closed | -$29K | – | 2504 |
|
|
2020
Q4 | $29K | Sell |
306
-13
| -4% | -$1.23K | ﹤0.01% | 1955 |
|
|
2020
Q3 | $30K | Buy |
+319
| New | +$30K | ﹤0.01% | 1868 |
|
|
2020
Q2 | – | Sell |
-76
| Closed | -$7K | – | 2130 |
|
|
2020
Q1 | $7K | Sell |
76
-643
| -89% | -$59.2K | ﹤0.01% | 2358 |
|
|
2019
Q4 | $78K | Buy |
719
+666
| +1,257% | +$72.3K | ﹤0.01% | 1271 |
|
|
2019
Q3 | $5K | Hold |
53
| – | – | ﹤0.01% | 2414 |
|
|
2019
Q2 | $5K | Hold |
53
| – | – | ﹤0.01% | 2412 |
|
|
2019
Q1 | $5K | Buy |
53
+10
| +23% | +$943 | ﹤0.01% | 2101 |
|
|
2018
Q4 | $3K | Buy |
+43
| New | +$3K | ﹤0.01% | 2216 |
|
|
2018
Q2 | – | Sell |
-21
| Closed | -$2K | – | 2626 |
|
|
2018
Q1 | $2K | Hold |
21
| – | – | ﹤0.01% | 2387 |
|
|
2017
Q4 | $2K | Buy |
+21
| New | +$2K | ﹤0.01% | 2368 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$4K | – | 2355 |
|
|
2017
Q1 | $4K | Buy |
+100
| New | +$4K | ﹤0.01% | 1801 |
|
|
2016
Q3 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 1531 |
|